ARVNSMALL

Arvinas, Inc.

HealthcareBiotechnology
$10.26
$0.00(-3.30%)
52W$5.90
$14.51
Updated May 7, 12:00 AM
RSI47
RS Rating49/99
Beta1.15
Volatility57%
F-Score4/9
Mkt Cap$656M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Arvinas, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 49), showing significant lag compared to the market leaders. Earnings contraction of 65% provides fundamental context to the price action. Investors should exercise caution due to high volatility (57% annualized), which requires wider risk management.

Relative Strength
49
out of 99
Lagging
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
1.15
vs S&P 500
ABOVE MKT
52W Position
51%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$11.43
50 SMA > 100 SMA$11.92
100 SMA > 150 SMA$11.48
150 SMA > 200 SMA$10.49

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$10.59-3.14%BELOW
50 SMA$11.43-10.24%BELOW
100 SMA$11.92-13.90%BELOW
150 SMA$11.48-10.63%BELOW
200 SMA$10.49-2.23%BELOW

Price Performance

1D-3.3%
1W+4.5%
1M-8.6%
3M-23.9%
6M+2.6%
YTD-10.5%
1Y+47.6%
3Y-25.4%
52-Week Trading Range51% from low
$10.26
52W Low$5.90
52W High$14.51

Technical Indicators

RSI (14)NEUTRAL
47.4
305070
VCP ScoreCOOL
1/10
Base depth: 46.6%

Risk Profile

Beta
1.15
52W Vol
57%
ATR
$0.49
Max DD (1Y)
-29%

Volume Analysis

Today
1.11M
50D Avg
808.2K
Vol Ratio
1.37x
Liquidity
MODERATE

Earnings Momentum

Q1'25+218%
$1.14
Q2'25-71%
$-0.84
Q3'25+29%
$-0.48
Q4'25-65%
$-1.04
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:+58.93%
3 Years:+25.96%
TTM:-0.30%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+55.96%

Stock Price CAGR

10 Years:-4.38%
5 Years:-30.47%
3 Years:-25.36%
1 Year:+47.63%

Return on Equity

10Y Avg:-56.2%
5Y Avg:-35.5%
3Y Avg:-36.3%
Last Year:-14.3%

Key Metrics

Market Cap$656M
Gross Margin98.0%
Net Margin-30.8%
Piotroski F-Score4/9

Frequently Asked Questions

Is ARVN in an uptrend right now?

ARVN has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is ARVN overbought or oversold?

ARVN's RSI (14) is 47. The stock is in neutral territory, neither overbought nor oversold.

Is ARVN outperforming the market?

ARVN has a Relative Strength (RS) Rating of 49 out of 99. ARVN is currently lagging the broader market.

Where is ARVN in its 52-week range?

ARVN is trading at $10.26, which is 71% of its 52-week high ($14.51) and 51% above its 52-week low ($5.90).

How volatile is ARVN?

ARVN has a Beta of 1.15 and 52-week volatility of 57%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.